Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Vivace Therapeutics

Request full access

A venture-backed, oncology-focused portfolio-based drug discovery and development company

San Mateo, United StatesFounded 2014Biotech & Life Sciences

About Vivace Therapeutics

Vivace Therapeutics is a small molecule drug discovery and development company with a focus on oncology. The company is centered on creating new treatments for cancer patients by targeting specific biological pathways. Its main focus is on the Hippo-YAP pathway, which is a key regulator of cell growth and is often dysregulated in cancer.

Vivace Therapeutics' business model is based on a portfolio-based approach to drug discovery and development. This means that the company is developing multiple drug candidates at the same time, which helps to diversify risk and increase the chances of success. The company's primary customers are patients with advanced cancers, such as mesothelioma, who have limited treatment options. Vivace Therapeutics operates in the highly competitive oncology market, which is characterized by rapid innovation and a constant need for new and effective treatments.

Source: Dealroom company data

At a glance

Status
Operational
Employees
13
Open positions
1
Dealroom signal
82.6/100
Industry
Health
Sub-industry
Pharmaceutical
Sector
Biotechnology, Oncology, Drug Development, Spinout, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

5 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES DOther financing Mar 2025 $35M $140M Cenova Capital · Canaan · RA Capital Management ↗
SERIES COther financing Dec 2020 $30M $120M Boxer Capital · Canaan · RA Capital Management · Tavistock Group —
Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Growth signals

Vivace Therapeutics website traffic

Latest recorded traffic for Vivace Therapeutics is 1.9K monthly website visits, down 9.5% over the last three months. Vivace Therapeutics's team grew 0% over the past year.

Latest monthly visits1.9K 3-month web change-9.5% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom
1 distinct opening shownExplore hiring signals →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Vivace Therapeutics in the San Mateo ecosystem

Live from Dealroom

The Vivace Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

10 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A5 investors entered at this stage

  • Canaan
  • WuXi Healthcare Ventures
  • Sequoia
  • Cenova Capital
  • Mission Bay Capital

Series B and later3 investors entered at this stage

Other known investors2 additional known investors

  • University of California, San Diego
  • University of California, San Francisco
Team profiled 6 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States87.5%
🇶🇦 Qatar12.5%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Vivace Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Vivace Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.